Author

Angela Kortesidis

Observed name: A. Kortesidis

Institutions: South Australia Pathology, Hanson Institute

Observed institutions: South Australia Pathology, National Institutes of Health, National Institute of Dental and Craniofacial Research, Hanson Institute, Weizmann Institute of Science, The University of Adelaide

OpenAlex ID: A5073766615

Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow

2003 · Stan Gronthos, Andrew C. W. Zannettino, et al. · Journal of Cell Science · 1,051

Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells

2005 · A. Kortesidis, Andrew Zannettino, et al. · Blood · 372

Elevated Serum Levels of Stromal-Derived Factor-1α Are Associated with Increased Osteoclast Activity and Osteolytic Bone Disease in Multiple Myeloma Patients

2005 · Andrew C.W. Zannettino, Amanda N. Farrugia, et al. · Cancer Research · 205

Defective osteogenesis of the stromal stem cells predisposes CD18-null mice to osteoporosis

2005 · Yasuo Miura, Masako Miura, et al. · Proceedings of the National Academy of Sciences · 76

Human mulipotential mesenchymal/stromal stem cells are derived from a discrete subpopulation of STRO-1bright/CD34 /CD45 /glycophorin-A-bone marrow cells

2007 · A. C.W. Zannettino, S. Paton, et al. · Haematologica · 73

Development of Novel Monoclonal Antibodies that Define Differentiation Stages of Human Stromal (Mesenchymal) Stem Cells

2011 · Ditte C. Andersen, Angela Kortesidis, et al. · Molecules and Cells · 14

Works count: 7

Citation count: 1,791

H-index: 6

I10-index: 6